BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26555156)

  • 1. MARCKSL1 exhibits anti-angiogenic effects through suppression of VEGFR-2-dependent Akt/PDK-1/mTOR phosphorylation.
    Kim BR; Lee SH; Park MS; Seo SH; Park YM; Kwon YJ; Rho SB
    Oncol Rep; 2016 Feb; 35(2):1041-8. PubMed ID: 26555156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmed cell death 6 (PDCD6) inhibits angiogenesis through PI3K/mTOR/p70S6K pathway by interacting of VEGFR-2.
    Rho SB; Song YJ; Lim MC; Lee SH; Kim BR; Park SY
    Cell Signal; 2012 Jan; 24(1):131-9. PubMed ID: 21893193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABARBP down-regulates HIF-1α expression through the VEGFR-2 and PI3K/mTOR/4E-BP1 pathways.
    Park SH; Kim BR; Lee JH; Park ST; Lee SH; Dong SM; Rho SB
    Cell Signal; 2014 Jul; 26(7):1506-13. PubMed ID: 24686084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of VEGF expression through interruption of the HIF‑1α and Akt signaling cascade modulates the anti‑angiogenic activity of DAPK in ovarian carcinoma cells.
    Park ST; Kim BR; Park SH; Lee JH; Lee EJ; Lee SH; Rho SB
    Oncol Rep; 2014 Feb; 31(2):1021-9. PubMed ID: 24337450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5,3'-Dihydroxy-6,7,4'-trimethoxyflavanone exerts its anticancer and antiangiogenesis effects through regulation of the Akt/mTOR signaling pathway in human lung cancer cells.
    Kim KM; Heo DR; Lee J; Park JS; Baek MG; Yi JM; Kim H; Bang OS
    Chem Biol Interact; 2015 Jan; 225():32-9. PubMed ID: 25446852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silent Information Regulator 1 Negatively Regulates Atherosclerotic Angiogenesis via Mammalian Target of Rapamycin Complex 1 Signaling Pathway.
    Chen R; Huang Z; Wang J; Chen X; Fu Y; Wang W
    Am J Med Sci; 2018 Aug; 356(2):168-176. PubMed ID: 30219159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. sMEK1 inhibits endothelial cell proliferation by attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1α signaling pathways.
    Kim BR; Seo SH; Park MS; Lee SH; Kwon Y; Rho SB
    Oncotarget; 2015 Oct; 6(31):31830-43. PubMed ID: 26378810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1α expression.
    Park MS; Kim BR; Dong SM; Lee SH; Kim DY; Rho SB
    Oncotarget; 2014 Jul; 5(13):4935-44. PubMed ID: 24952732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascofuranone suppresses EGF-induced HIF-1α protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells.
    Jeong YJ; Cho HJ; Magae J; Lee IK; Park KG; Chang YC
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):542-50. PubMed ID: 24096035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visfatin exerts angiogenic effects on human umbilical vein endothelial cells through the mTOR signaling pathway.
    Park JW; Kim WH; Shin SH; Kim JY; Yun MR; Park KJ; Park HY
    Biochim Biophys Acta; 2011 May; 1813(5):763-71. PubMed ID: 21329734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells.
    Skurk C; Maatz H; Rocnik E; Bialik A; Force T; Walsh K
    Circ Res; 2005 Feb; 96(3):308-18. PubMed ID: 15662032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquiritigenin inhibits serum-induced HIF-1α and VEGF expression via the AKT/mTOR-p70S6K signalling pathway in HeLa cells.
    Xie SR; Wang Y; Liu CW; Luo K; Cai YQ
    Phytother Res; 2012 Aug; 26(8):1133-41. PubMed ID: 22170854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WIF1 can effectively co-regulate pro-apoptotic activity through the combination with DKK1.
    Ko YB; Kim BR; Yoon K; Choi EK; Seo SH; Lee Y; Lee MA; Yang JB; Park MS; Rho SB
    Cell Signal; 2014 Nov; 26(11):2562-72. PubMed ID: 25086206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian target of rapamycin mediates the angiogenic effects of leptin in human hepatic stellate cells.
    Aleffi S; Navari N; Delogu W; Galastri S; Novo E; Rombouts K; Pinzani M; Parola M; Marra F
    Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G210-9. PubMed ID: 21252047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways.
    Shen K; Ji L; Gong C; Ma Y; Yang L; Fan Y; Hou M; Wang Z
    Biochem Pharmacol; 2012 Sep; 84(6):784-92. PubMed ID: 22771629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysyl oxidase-like 2 (LOXL2) controls tumor-associated cell proliferation through the interaction with MARCKSL1.
    Kim BR; Dong SM; Seo SH; Lee JH; Lee JM; Lee SH; Rho SB
    Cell Signal; 2014 Sep; 26(9):1765-73. PubMed ID: 24863880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoflurane preconditioning increases survival of rat skin random-pattern flaps by induction of HIF-1α expression.
    Sun Y; Li QF; Zhang Y; Hu R; Jiang H
    Cell Physiol Biochem; 2013; 31(4-5):579-91. PubMed ID: 23635649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6K signaling pathways.
    Pratheeshkumar P; Budhraja A; Son YO; Wang X; Zhang Z; Ding S; Wang L; Hitron A; Lee JC; Xu M; Chen G; Luo J; Shi X
    PLoS One; 2012; 7(10):e47516. PubMed ID: 23094058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delphinidin inhibits angiogenesis through the suppression of HIF-1α and VEGF expression in A549 lung cancer cells.
    Kim MH; Jeong YJ; Cho HJ; Hoe HS; Park KK; Park YY; Choi YH; Kim CH; Chang HW; Park YJ; Chung IK; Chang YC
    Oncol Rep; 2017 Feb; 37(2):777-784. PubMed ID: 27959445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.